97131 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Salmonella (G)
OPTIMIZED CROSSLINKERS FOR TRAPPING A TARGET ON A SUBSTRATE
#2ANTIBODIES AGAINST MICROORGANISMS AND USES THEREOF
#3ENGINEERED BINDING PROTEINS FOR RECOGNITION OF BACTERIA
#4COMPOSITIONS AND METHODS RELATING TO TYPHOID TOXIN SUBUNIT PLTC
#5Optimized crosslinkers for trapping a target on a substrate
#6ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF
#7Antibodies against microorganisms and uses thereof
#8Eradication of bacterial biofilm using anti-amyloid monoclonal antibodies
#9SYNTHETIC BINDING AGENTS FOR LIMITING PERMEATION THROUGH MUCUS
#10Eradication of bacterial biofilm using anti-amyloid monoclonal antibodies
#11OPTIMIZED CROSSLINKERS FOR TRAPPING A TARGET ON A SUBSTRATE
#12APPARATUS AND METHOD FOR DETECTING MICROBIAL CONTAMINATION
#13Apparatus and method for detecting microbial contamination
#14ANTI-SALMONELLA ANTIBODIES AND USES THEREOF
#15Antibodies against microorganisms and uses thereof
#16Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
#17Optimized crosslinkers for trapping a target on a substrate
#18Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
#19Bacterial minicells for delivering nucleic acid adjuvants and methods of using the same
#20Anti-salmonella antibodies and uses thereof
#21Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
#22Bacterially derived intact minicells that encompass plasmid free DNA and methods of using the same
#23Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
#24Expression of a single chain antibody against in
#25Antibody molecule-drug conjugates and uses thereof
#26Method of treating protozoal gastrointestinal disorders in immunocompromised patients
#27PEPTIDE AGONISTS OF TOLL-LIKE RECEPTOR 5 LIGAND AND METHOD OF USE
#28Methods of Improving the Therapeutic Efficacy and Utility of Antibody Fragments
#29AN ISOLATED IMMUNOGENIC BACTERIAL ANTIGEN AND ITS USE IN THE PREVENTION AND TREATMENT OF INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA
#30Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
#31Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
#32Compositions and methods for inhibiting pathogen infection
#33Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
#34Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
#35Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
#36Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
#37METHOD FOR DETECTING A SALMONELLA INFECTION
#38METHODS OF IMPROVING THE THERAPEUTIC EFFICACY AND UTILITY OF ANTIBODY FRAGMENTS
#39SALMONELLA MARKER VACCINE
#40Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
#41Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells
#42ANTIBODIES AGAINST FLAGELLIN AND USES THEREOF
#43Antibodies against flagellin and uses thereof
#44Antibodies against flagellin and uses thereof
#45Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells
#46Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
#47Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
#48Development of human monoclonal antibodies and uses thereof
#49Crystal of a transporter-ligand complex and methods of use
#50Development of human monoclonal antibodies and uses thereof
#51Antimicrobial activity of antibodies producing reactive oxygen species
#52Single chain antibody and use thereof
#53Reaction solution for cell-free protein synthesis, method of preparing the same, and protein synthesis method using the same
#54Antimicrobial activity of antibodies